NCI needs a $250M raise in FY24 to maintain paylines, grant funding levels amid crippling continuing resolutions

Vinay Prasad describes his Vanderbilt colleagues as “despicable,” raising new questions about physicians’ conduct on social media

Conversation with The Cancer Letter

Prasad could not have had patient data when he called Vanderbilt colleagues “despicable”

Alec Kimmelman named director of Perlmutter Cancer Center, quickly replacing ousted Benjamin Neel

Guest Editorial

For cancer patients, traditional Medicare is better than Medicare Advantage

In Brief

Eduardo Sotomayor named vice president and executive director of Tampa General Hospital’s Cancer Institute

Glenn Lesser named deputy director of the Atrium Health Wake Forest Baptist CCC

Sarki Abdulkadir, Patricia Robinson named to senior leadership positions at Northwestern

Louise Ligresti named chief of cancer survivorship at Rutgers Cancer Institute

Morhaf Al Achkar named associate center director for education at Karmanos

Bryan Burt named chief of thoracic surgery at UCLA Health

Drugs & Targets

FDA approves Xtandi for non-metastatic castration-sensitive prostate cancer with biochemical recurrence

FDA grants Breakthrough Therapy Designation to epcoritamab-bysp

FDA approves Keytruda + chemo for HER2-negative gastric or GEJ cancer

FDA approves Augtyro for ROS1-positive NSCLC

FDA approves Truqap + fulvestrant for breast cancer

FDA approves Edison histotripsy device to treat liver tumors

In The Clinic

ESMO discussants urge physicians to prescribe lower dose of Amgen’s sotorasib

After revolutionizing treatment of blood cancers, imatinib stands poised to eradicate malaria

Real-world Evidence

Real-world tumor response rate can serve as a clinical endpoint, Friends pilot study shows
FDA says raw images enrich the data when used with clinician assessments

ASCO’s Julie Gralow: “There was clearly a shortage of drug, but there was a bigger problem of maldistribution”

Carolyn Bertozzi focused on bioorthogonal chemistry in 1996 and won the Nobel Prize in 2022
This is how her discovery got to cancer clinical trials

Latest Issue

Read the latest issue

DOWNLOAD THE PDF

NEWS ALERTS

Stay up to date on the latest news in oncology by joining our mailing list.

UPCOMING EVENTS

Feb 2024

NCCN 2024 Breast Cancer Congress

Apr 2024

NCCN 2024 Annual Conference

View All Events

Conversations with The Cancer Letter

Paige’s Razik Yousfi: Biden has set expectations for AI, but details will come via federal guidelines

John Carpten: City of Hope’s national strategy drew me to this opportunity

ARPA-H’s Renee Wegrzyn on cancer research: “Think big. Really big. I’m handing you a magic wand.”

Mark Evers tells us how Markey went from Cancer Center to Comprehensive designation in 10 years

Contributors

Otis W. Brawley, MD, MACP

Worta McCaskill-Stevens understood the importance of explaining cancer prevention

Division of Cancer Prevention staff

Worta McCaskill-Stevens, MD: An appreciation for a driving force in cancer prevention and addressing cancer disparities

Ruben A. Mesa, MD

Integrating cancer care: the Advocate Health experience

Peter B. Bach, MD

Liquid biopsy cancer screening: We’ll need more than one size to fit all

Trending Stories

Vinay Prasad describes his Vanderbilt colleagues as “despicable,” raising new questions about physicians’ conduct on social media
Prasad could not have had patient data when he called Vanderbilt colleagues “despicable”
Alec Kimmelman named director of Perlmutter Cancer Center, quickly replacing ousted Benjamin Neel
Suspensions, public outrage ensue as tensions over Middle East sweep through oncology
NYU Cancer Center Director Benjamin Neel suspended over social media posts
How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
Worta McCaskill-Stevens understood the importance of explaining cancer prevention

Recent Issues

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.